Back to results
US 10,471,078 B2Granted
Certain chemical entities, compositions, and methods
AssigneeSuzhou Neupharma Co., Ltd.
InventorXiangping Qian
Life of this patent
Estimating the term…
Abstract
Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
Claims21
A method of treating cancer in a subject, the method comprising administering to the subject in need thereof a therapeutically effective amount of a compound of Formula III:
- or a pharmaceutically acceptable salt thereof, wherein:
- R5 is chosen from hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl;
- and
- R6 is chosen from optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted acyl, optionally substituted alkoxycarbonyl, and —P(═O)(OR7)(OR8), where R7 and R8 are independently chosen from hydrogen and optionally substituted alkyl;
- wherein the cancer is selected from the group consisting of colorectal cancer, liver cancer, lung cancer, breast cancer, prostate cancer, pancreatic cancer, brain cancer, and oral cancer.
2 more elements
Dependencies are inferred from the claim text.